Cost-effectiveness of systematic depression treatment for high utilizers of general medical care

Archives of General Psychiatry

Volumn 58, Issue 2, 2001, Pages 181-187

  Simon, G E ^a   Manning, W G ^a   Katzelnick, D J ^a   Pearson, S D ^a   Henk, H J ^a   Helstad, C P ^a  

^a CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NORTRIPTYLINE; SERTRALINE;

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATIENT EDUCATION;

EID: 0035130575     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.58.2.181     Document Type: Article

References (41)

1. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study
2. Common mental disorders and disability across cultures
3. The functioning and well-being of depressed patients: Results from the Medical Outcome Study
4. Patterns of antidepressant use in community practice
5. Prescribing patterns of antidepressant medications for depression in an HMO
6. Medication management of depression in the United States and Canada
7. Use of minor tranquilizers and antidepressant medications by depressed outpatients: Results from the Medical Outcomes Study
8. Treating major depression in primary care practice: Eight-month clinical outcomes
9. Collaborative management to achieve treatment guidelines: Impact on depression in primary care
10. A multifaceted intervention to improve treatment of depression in primary care
11. Stepped collaborative care for primary care patients with persistent symptoms of depression
12. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care
13. Randomized trial of a depression management program in high utilizers of medical care
14. Treatment costs, cost offset, and cost-effectivness of collaborative management of depression
15. Cost-effectiveness of treatments for major depression in primary care practice
16. Health care costs associated with depressive and anxiety disorders in primary care
17. Health care costs of primary care patients with recognized depression
18. Depressive symptoms and the cost of health services in HMO patients aged 65 and older: A 4-year prospective study
19. Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization
20. The effects of psychological distress and psychological well-being on use of medical services
21. Depression among high utilizers of medical care
22. A rating scale for depression
23. Modeling risk using generalized linear models
24. The logged dependent variable, heteroscedasticity, and the retransformation problem
25. Reflecting uncertainty in cost-effectiveness analyses
26. Accounting for future costs in medical cost-effectiveness analysis
27. Patient-assigned health state utilities for depression-related outcomes: Differences by depression severity and antidepressant medications
28. Using general measures of health-related quality of life to assess mental health outcomes
29. The Beaver Dam health outcomes study: Initial catalog of health state quality factors
30. Preliminary longitudinal assessment of quality of life in patient with major depression
31. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices
32. Five-hundred life-saving interventions and their cost-effectiveness
33. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
34. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease
35. Depression, use of medical services, and cost-offset effects
36. The value of mental health care at the system level: The case of treating depression